CORE LABORATORIES INC (CLB) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:CLB - US21867A1051 - Common Stock
16.95 USD
+0.92 (+5.74%)
16.95 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 48% to CLB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 15.64. This target is -7.73% below the current price.
CLB was analyzed by 10 analysts. The buy percentage consensus is at 48. So analysts seem to be rather neutral about CLB.
In the previous month the buy percentage consensus was at a similar level.
CLB was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-07-16 | Stifel | Maintains | Hold -> Hold |
| 2025-05-13 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-04-15 | Stifel | Maintains | Hold -> Hold |
| 2025-03-12 | Citigroup | Upgrade | Sell -> Neutral |
| 2025-02-20 | Citigroup | Maintains | Sell -> Sell |
| 2024-10-31 | Citigroup | Maintains | Sell -> Sell |
| 2024-07-26 | Stifel | Maintains | Hold -> Hold |
| 2024-07-15 | B of A Securities | Maintains | Underperform -> Underperform |
| 2024-07-15 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-04-26 | Stifel | Maintains | Hold -> Hold |
| 2024-04-15 | B of A Securities | Maintains | Underperform -> Underperform |
| 2024-02-05 | Stifel | Maintains | Hold -> Hold |
| 2024-01-29 | Stifel | Maintains | Hold -> Hold |
| 2023-09-18 | Citigroup | Maintains | Sell -> Sell |
| 2023-07-31 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2023-06-30 | Citigroup | Downgrade | Neutral -> Sell |
| 2023-05-01 | Piper Sandler | Maintains | Neutral |
| 2023-04-28 | Stifel | Maintains | Hold |
| 2023-04-18 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2023-02-07 | Citigroup | Maintains | Neutral |
| 2023-01-09 | B of A Securities | Upgrade | Underperform -> Neutral |
| 2022-10-07 | Citigroup | Upgrade | Sell -> Neutral |
| 2022-09-26 | Morgan Stanley | Downgrade | Equal-Weight -> Underweight |
| 2022-08-01 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-07-13 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-05-02 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-04-18 | Piper Sandler | Downgrade | Neutral -> Underweight |
| 2022-04-11 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-01-18 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-12-07 | Morgan Stanley | Maintains | Equal-Weight |
CORE LABORATORIES INC / CLB FAQ
Can you provide the average price target for CORE LABORATORIES INC stock?
10 analysts have analysed CLB and the average price target is 15.64 USD. This implies a price decrease of -7.73% is expected in the next year compared to the current price of 16.95.
How do analysts rate CORE LABORATORIES INC (CLB)?
The consensus rating for CORE LABORATORIES INC (CLB) is 48 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
How many analysts cover CORE LABORATORIES INC (CLB) stock?
The number of analysts covering CORE LABORATORIES INC (CLB) is 10.